CMS to pay more for CPAP alternative

Tuesday, August 7, 2018

MINNETONKA, Minn. – An alternative to CPAP therapy has been approved by CMS for a new technology add-on payment to hospitals. The NTAP program will provide additional reimbursement on top of the standard Medicare Severity Diagnosis Related Group payment to hospitals under the Medicare Hospital Inpatient Prospective System for Respicardia’s remedē System, an implantable device that treats the effects of central sleep apnea by restoring a more normal breathing patter during sleep. The add-on payment goes into effect Oct. 1. The NTAP program recognizes innovative medical technologies that substantially improve the diagnosis or treatment of Medicare beneficiaries.